Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: 

• Elevai Labs (ELAB), 938% surge in interest
• Mereo Biopharma (MREO), 96% surge in interest
• Arcturus Therapeutics (ARCT), 28% surge in interest

Pipeline and key clinical candidates for these companies:

Elevai Labs specializes in medical aesthetics and biopharmaceutical drug development, focusing on innovations for skin aesthetics and treatments tied to obesity and metabolic health. Driven by a commitment to scientific research, Elevai aims to transform personal health and beauty, the company states.

Mereo BioPharma is a biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The company has two rare disease product candidates, setrusumab for the treatment of Osteogenesis Imperfecta, or OI, and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease and Bronchiolitis Obliterans Syndrome.

Arcturus Therapeutics is a late-stage clinical mRNA medicines and vaccines company whose pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for COVID-19 and Influenza, and other programs to potentially treat ornithine transcarbamylase, or OTC, deficiency, and cystic fibrosis, or CF. The company’s partnered programs include glycogen storage disease type III and hepatitis B virus.

Recent news on these stocks:

August 26

Elevai Labs announces the completion of a clinical study examining the effectiveness of Elevai exosomes on facial appearance. The data, pending peer review, from the clinical study was internally reviewed by the company, and the results show Elevai enfinity to be safe and tolerable with significant improvement noted across many aspects of skin appearance. Elevai aims to publish the full study results in the near future. The study assessed the use of twice-daily Elevai enfinity on 29 study participants over a 12-week period, to determine the efficacy on facial appearance, including measurements like facial firmness, skin tone, wrinkles and smoothness. The study investigated healthy subjects between 40-70 years of age with mild to moderate facial photoaging and sensitive skin.

Hear more from InvestingChannel by signing up for The Spill.

About “Biotech Alert”

The Fly will report on a selection of biotech stocks seeing a surge in interest from retail and financial professional investors, based on data from InvestingChannel.

This Fly exclusive recap reveals the biotech stocks that are seeing a spike in searches among the 20-plus million retail and financial professional investors through InvestingChannel’s online financial news media ecosystem.

This increased attention from the investors may be in response to, or advance of, outsized moves for stocks in the biotech sector, which tend to be volatile and prone to sharp swings in share price around binary events such as clinical study results and FDA approvals.